Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?

被引：87

作者：

Brock, CS ^{[1
]}

Meikle, SR ^{[1
]}

Price, P ^{[1
]}

机构：

[1] ROYAL PRINCE ALFRED HOSP,PET DEPT,CAMPERDOWN,NSW 2050,AUSTRALIA

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1997年 / 24卷 / 06期

关键词：

FDG; oncology; positron emission tomography;

D O I：

10.1007/BF00841411

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Fluoro-deoxyglucose (FDG) is a metabolic marker, which follows the same route into cells as that of glucose, and it can be radiolabelled with fluorine-18, F-18-FDG making it suitable for imaging with positron emission tomography (PET). The fact that rapidly proliferating cells such as tumour cells accumulate F-18-FDG more avidly than those with a normal turnover rate has given rise to its potential in oncology. The rationale and previous published uses of F-18-FDG in oncology are reviewed, together with the various analysis techniques and associated methodological difficulties.

引用

页码：691 / 705

页数：15

共 50 条

[41] Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography
Zhao Quan-ming
Feng Ting-ting
Zhao Xin
Xu Zhan-min
Liu Yu
Li De-peng
Li Li-qin
Su Gong
Zhang Xiao-xia
CHINESE MEDICAL JOURNAL, 2011, 124 (06) : 911 - 917
[42] Cardiac fluorine-18 fluorodeoxyglucose imaging using a dual-head gamma camera with coincidence detection: a clinical pilot study
De Sutter, J
De Winter, F
Van de Wiele, C
De Bondt, P
D'Asseler, Y
Dierckx, R
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (06) : 676 - 685
[43] Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Therapeutic Response to Chemotherapy for Metastatic Transitional Cell Carcinoma
Giannatempo, Patrizia
Alessi, Alessandra
Miceli, Rosalba
Raggi, Daniele
Fare, Elena
Nicolai, Nicola
Serafini, Gianluca
Padovano, Barbara
Piva, Luigi
Biasoni, Davide
Torelli, Tullio
Catanzaro, Mario
Stagni, Silvia
Maffezzini, Massimo
Mariani, Luigi
Gianni, Alessandro M.
Sonpavde, Guru
Salvioni, Roberto
Necchi, Andrea
Crippa, Flavio
CLINICAL GENITOURINARY CANCER, 2014, 12 (06) : 433 - 439
[44] Are restrictions to behaviour of patients required following fluorine-18 fluorodeoxyglucose positron emission tomographic studies?
Bernadette Cronin
Paul K. Marsden
Michael J. O’Doherty
European Journal of Nuclear Medicine, 1999, 26 : 121 - 128
[45] Are restrictions to behaviour of patients required following fluorine-18 fluorodeoxyglucose positron emission tomographic studies?
Cronin, B
Marsden, PK
O'Doherty, MJ
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (02) : 121 - 128
[46] Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results
Sugawara, Y
Braun, DK
Kison, PV
Russo, JE
Zasadny, KR
Wahl, RL
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (09) : 1238 - 1243
[47] Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer
Grunwald, F
Schomburg, A
Bender, H
Klemm, E
Menzel, C
Bultmann, T
Palmedo, H
Ruhlmann, J
Kozak, B
Biersack, HJ
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (03): : 312 - 319
[48] Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results
Yoshifumi Sugawara
Daniel K. Braun
Paul V. Kison
Joseph E. Russo
Kenneth R. Zasadny
Richard L. Wahl
European Journal of Nuclear Medicine, 1998, 25 : 1238 - 1243
[49] Fluorine-18 fluorodeoxyglucose positron emission tomography for cardiac sarcoidosis—is it time to consider a new radiotracer?
Georgios Christopoulos
Panithaya Chareonthaitawee
EJNMMI Research, 7
[50] Fluorine-18 labeled amino acids for tumor PET/CT imaging
Qi, Yiqiang
Liu, Xiaohui
Li, Jun
Yao, Huiqian
Yuan, Shuanghu
ONCOTARGET, 2017, 8 (36) : 60581 - 60588

← 1 2 3 4 5 →